Why the study?
Does hemodialysis improve symptoms in a peritoneal dialysis patient with life-threatening hypermagnesemia?
Does hemodialysis improve symptoms in a peritoneal dialysis patient with life-threatening hypermagnesemia?
Hemodialysis provides rapid clearance of magnesium and should be preferred for treating symptomatic hypermagnesemia in peritoneal dialysis patients.
Hemodialysis may rapidly resolve symptoms in peritoneal dialysis patients with hypermagnesemia; hypothesis-generating and leaves open preferred use.
Hypermagnesemia is rarely seen in peritoneal dialysis (PD) patients because PD can lower the plasma magnesium (Mg) concentration effectively. In this report, a continuous ambulatory peritoneal dialysis (CAPD) patient with life-threatening hypermagnesemia treated by hemodialysis (HD) is presented. A 52-year-old male patient on PD treatment was admitted to our clinic with complaints of fatigue and muscle weakness. Decrease in deep tendon reflexes (DTR), decrease in muscle strength at bilateral upper and lower extremities, and increased level of magnesium (7.7 mg/dl) were detected. Bradycardia, prolongation of the P-R interval, and an increase in Q-T interval were found on the electrocardiography. HD was performed two times. After HD, all the signs and symptoms of the patient improved. HD is a dialysis modality that should be preferred in the treatment of symptomatic patients with hypermagnesemia, because of providing more rapid clearance of Mg.
No takes yet. Share an insight, caveat, or question.
Yaprak et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: